Literature DB >> 10802697

Chemotherapeutic drugs--more really is not better.

I J Fidler, L M Ellis.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10802697     DOI： 10.1038/74969

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas.

Authors:  Leandro E Mainetti; Viviana R Rozados; Ana Rossa; R Daniel Bonfil; O Graciela Scharovsky
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-27       Impact factor: 4.553

Review 2.  Metronomics: towards personalized chemotherapy?

Authors:  Nicolas André; Manon Carré; Eddy Pasquier
Journal:  Nat Rev Clin Oncol       Date:  2014-06-10       Impact factor: 66.675

3.  Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicin.

Authors:  Jing Li; Shufeng Zhou; Hung Huynh; Wei Duan; Eli Chan
Journal:  Pharm Res       Date:  2005-08-13       Impact factor: 4.200

4.  Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.

Authors:  Huang-Chiao Huang; Imran Rizvi; Joyce Liu; Sriram Anbil; Ashish Kalra; Helen Lee; Yan Baglo; Nancy Paz; Douglas Hayden; Steve Pereira; Brian W Pogue; Jonathan Fitzgerald; Tayyaba Hasan
Journal:  Cancer Res       Date:  2017-11-29       Impact factor: 12.701

Review 5.  Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.

Authors:  József Tímár; Andrea Ladányi; István Peták; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

Review 6.  Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package.

Authors:  Ankur Bahl; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2012-04-28       Impact factor: 1.967

Review 7.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

8.  Metronomic chemotherapy: changing the paradigm that more is better.

Authors:  O G Scharovsky; L E Mainetti; V R Rozados
Journal:  Curr Oncol       Date:  2009-03       Impact factor: 3.677

9.  Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro.

Authors:  Nyla Dil; Abhijit G Banerjee
Journal:  Head Neck Oncol       Date:  2012-06-08

10.  Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft.

Authors:  G Petrangolini; G Cassinelli; G Pratesi; M Tortoreto; E Favini; R Supino; C Lanzi; S Belluco; F Zunino
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.